Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

ERYTECH Pharma S.A. - Filing #880081

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Foreign exchange gain (loss) [abstract]
Foreign exchange gain (loss)
3 570 EUR
3 028 EUR
673,000 EUR
Reserve of exchange differences on translation
1 215 EUR
1 744 EUR
1 344 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
26 720 EUR
30 770 EUR
36 962 EUR
Current assets
40 048 EUR
49 632 EUR
81 583 EUR
Non-current liabilities
23 918 EUR
24 516 EUR
13 105 EUR
Current liabilities
20 005 EUR
29 347 EUR
19 880 EUR
Revenue
EUR
EUR
EUR
Profit (loss)
53 797 EUR
53 797 EUR
73 300 EUR
73 300 EUR
62 659 EUR
62 659 EUR
Other comprehensive income
68,000 EUR
528,000 EUR
460,000 EUR
381,000 EUR
19,000 EUR
400,000 EUR
38,000 EUR
1 237 EUR
1 199 EUR
Comprehensive income
68,000 EUR
EUR
528,000 EUR
53 797 EUR
EUR
54 257 EUR
72 919 EUR
19,000 EUR
EUR
400,000 EUR
EUR
73 300 EUR
38,000 EUR
1 237 EUR
61 460 EUR
EUR
62 659 EUR
EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.